High Quality Antibody Reagents

Catalogue

Print Friendly and PDF

Mouse anti Human Caspase-9

Catalog number: X1177M
Clone LAAP6 96 2-22
Isotype IgG1, kappa
Product Type Monoclonal Antibody
Units 100 µg
Host Mouse
Species Reactivity Human
Application Western Blotting

Background
Caspases are key effectors of programmed cell death. They are synthesized as inactive proenzymes which are activated by cleavage at a specific aspartate residue to form two subunits. These subunits are normally linked together by a linker which may be involved in the regulation of the different caspases. Caspase-9 is a member of the CED-3 family and bear high similarity to caspase-3. Procaspase-9 can be activated by either caspase-3 or granzyme B, although they cleave the proenzyme to different size subunits. Cleavage by granzyme B produces an active enzyme which is capable of cleaving PARP. Also, the ability of caspase-3 to activate caspase-9 seems to suggest that caspase-9 is further downstream of caspase-3 and may be involved in later changes in cells observed undergoing apoptosis.

Synonyms: Cysteine-requiring Aspartate Protease-9; iCE-like apoptotic protease 6;Apoptotic protease Mch-6; Apoptotic protease-activating factor 3

Source

Immunogen: Hybridoma produced by the fusion of splenocytes from mice immunized with recombinant human capase-9 protein and mouse myeloma cells.

Product

Product Form: Unconjugated

Formulation: Provided as solution in phosphate buffered saline with 0.08% sodium azide

Purification Method: Protein A/G Chromatography

Concentration: See vial for concentration

Applications
Detects proenzyme form of human Caspase-9 by Western blot analysis as well as one of the cleavage products after treatment with thapsigargin. Optimal concentration should be evaluated by serial dilutions.

Functional Analysis: Western Blotting

Positive Control: MCF-7 cell lines

Storage
Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles

Product Stability: See expiration date on vial

Shipping Conditions: Ship at ambient temperature, freeze upon arrival

Caution
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. It may contain hazardous ingredients. Please refer to the Safety Data Sheets (SDS) for additional information and proper handling procedures. Dispose product remainders according to local regulations.This datasheet is as accurate as reasonably achievable, but Nordic-MUbio​ accepts no liability for any inaccuracies or omissions in this information.

References
1. Cohen, G.M., et al. Caspases: the executioners of apoptosis. Biochem. J. 1997, 326, 1-16 2. Stennicke, H.R., et al. Caspase-9 can be activated without proteolytic processing. J. Biol. Chem. 1999, 274, 8359-8362 3. Kuida, K. Caspase-9. Int. J. Biochem. Cell Biol. 2000, 32, 121-124

Protein Reference(s)

Database Name: SwissProt

Accession Number: P55211

Species Accession: Human

Safety Datasheet(s) for this product:

NM_Sodium Azide

SKU: X1177M Categories : Primary antibodies, Primary antibodies, Monoclonal Antibody
Western blot analysis using Caspase-9 antibody on MCF-7 cells negative (-) and positive (+) for caspase-3 and showing the proenzyme form of caspase-9 and one of the cleavage products after treatment with thapsigargin for 48 hours. Western blot analysis using Caspase-9 antibody on MCF-7 cells negative (-) and positive (+) for caspase-3 and showing the proenzyme form of caspase-9 and one of the cleavage products after treatment with thapsigargin for 48 hours.
Western blot analysis using Caspase-9 antibody on MCF-7 cells negative (-) and positive (+) for caspase-3 and showing the proenzyme form of caspase-9 and one of the cleavage products after treatment with thapsigargin for 48 hours.

Western blot analysis using Caspase-9 antibody on MCF-7 cells negative (-) and positive (+) for caspase-3 and showing the proenzyme form of caspase-9 and one of the cleavage products after treatment with thapsigargin for 48 hours.